← U S PHYSICAL THERAPY INC /NV USPH
Market Price
$81.06
Market Cap
$1.26B
P/E Ratio
57.08
Revenue (FY 2025)
↑16.3% YoY
$780.99M
3-Yr CAGR: 12.2%
Net Income
↑26.0% YoY
$39.58M
Net Margin: 5.1%
Free Cash Flow
↓-7.2% YoY
$60.99M
FCF Yield: 4.85%
EPS (Diluted)
↓-22.8% YoY
$1.42
Basic: $1.42
Return on Equity
Efficiency
8.3%
ROA: 28.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (USPH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $356.5M | — | $82.0M | $20.6M | — | $1.64 | — | $51.0M | $42.8M | — |
| FY 2017 | $414.1M | +16.1% | $90.6M | $22.3M | +8.3% | $1.76 | +7.3% | $56.5M | $49.4M | +15.5% |
| FY 2018 | $453.9M | +9.6% | $101.7M | $34.9M | +56.7% | $1.31 | -25.6% | $73.0M | $65.8M | +33.1% |
| FY 2019 | $482.0M | +6.2% | $112.5M | $40.0M | +14.8% | $2.45 | +87.0% | $62.4M | $52.3M | -20.6% |
| FY 2020 | $423.0M | -12.2% | $94.5M | $35.2M | -12.1% | $2.48 | +1.2% | $100.0M | $92.4M | +76.7% |
| FY 2021 | $495.0M | +17.0% | $117.2M | $40.8M | +16.0% | $2.41 | -2.8% | $76.4M | $68.2M | -26.1% |
| FY 2022 | $553.1M | +11.7% | $112.0M | $32.2M | -21.2% | $2.25 | -6.6% | $58.5M | $50.3M | -26.3% |
| FY 2023 | $604.8M | +9.3% | $121.5M | $28.2M | -12.2% | $1.28 | -43.1% | $82.0M | $72.7M | +44.5% |
| FY 2024 | $671.3M | +11.0% | $123.9M | $31.4M | +11.3% | $1.84 | +43.8% | $74.9M | $65.8M | -9.5% |
| FY 2025 | $781.0M | +16.3% | $149.7M | $39.6M | +26.0% | $1.42 | -22.8% | $75.1M | $61.0M | -7.2% |
Valuation
Market Price
$81.06
Market Cap
$1.26B
Enterprise Value
$1.38B
P/E Ratio
57.08
P/B Ratio
2.59
FCF Yield
4.85%
Dividend Yield
2.22%
Shares Outstanding
Profitability & Margins
Gross Margin
19.17%
Operating Margin
11.10%
Net Margin
5.07%
Return on Equity (ROE)
8.31%
Return on Assets (ROA)
28.28%
Asset Turnover
5.58x
Revenue 3-Yr CAGR
12.19%
Financial Health & Liquidity
Current Ratio
1.73
Cash Ratio
0.44
Debt / Equity
0.341
Debt / Assets
1.161
Cash & Equivalents
$35.57M
Total Debt
$162.46M
Book Value / Share
$31.31
Cash Flow Efficiency
Operating Cash Flow
$75.06M
Capital Expenditures (CapEx)
$14.07M
Free Cash Flow
$60.99M
OCF / Revenue
9.61%
FCF / Revenue
7.81%
FCF 3-Yr CAGR
6.64%
Per Share Metrics
EPS (Diluted)
$1.42
EPS (Basic)
$1.42
Dividends / Share
$1.80
Book Value / Share
$31.31
EPS YoY Growth
-22.83%
Balance Sheet (FY 2025)
Total Assets
$139.99M
Total Liabilities
$80.98M
Stockholders' Equity
$476.43M
Current Assets
$139.99M
Current Liabilities
$80.98M